Compound 621
Identifiers
- Canonical SMILES:
Fc1ccc(cc1C#N)S(=O)(=O)N1[C@H]([C@@H](c2ccc(Cl)cc2)n2c1cccc2=O)c1ccc(Cl)cc1
- IUPAC name:
5-[[(2R,3S)-2,3-bis(4-chlorophenyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]-2-fluorobenzonitrile
- InChi:
InChI=1S/C26H16Cl2FN3O3S/c27-19-8-4-16(5-9-19)25-26(17-6-10-20(28)11-7-17)32(23-2-1-3-24(33)31(23)25)36(34,35)21-12-13-22(29)18(14-21)15-30/h1-14,25-26H/t25-,26+/m1/s1
- InChiKey:
MBFAQFKAHAKPOL-FTJBHMTQSA-N
External links
67238069 |
External search
Bibliography (1)
Publication | Name |
---|---|
Dominique Romyr, Robert Alan Goodnow, Qi Qiao, Binh Thanh Vu, F. Hoffmann-La Roche Ag. . Diphenyl-dihydro-imidazopyridinones None. | 85 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.66 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 539.03 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 6.00 | |||
TPSA | 81.48 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008125487 | 85 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 6.66 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4433 | Elismetrep | DB15287 | |
0.4398 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.4097 | BMS-214662 | DB12234 | |
0.3978 | (2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE | DB07568 | |
0.3939 | 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide | DB07056 | |
0.3903 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.3735 | Relcovaptan | DB13929 | |
0.3731 | (S)-Indapamide | DB07467 | |
0.3731 | Indapamide | DB00808 | |
0.3728 | Tianeptine | DB09289 | |
0.3724 | Nelivaptan | DB12643 | |
0.3720 | Ramatroban | DB13036 | |
0.3686 | (3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DB07747 | |
0.3627 | Omidenepag isopropyl | DB15071 | |
0.3620 | Trelagliptin | DB15323 |